Several over-the-counter eye products have been voluntarily recalled following a U.S. Food and Drug Administration audit that uncovered issues related to manufacturing practices. The recall, issued by AvKARE, involves Artificial Tears Ophthalmic Solution, a commonly used product for treating dry or irritated eyes. According to the recall announcement posted by the company, the products were pulled due to deviations in manufacturing that may have compromised quality and potentially pose a risk to consumers.
The audit findings did not confirm specific health effects resulting from the use of these eye drops, but the company emphasized that the deviations in manufacturing could result in unacceptable quality levels. This opens up the possibility of health risks, especially when applied to a sensitive area like the eyes. Though no adverse effects have been reported so far, AvKARE has taken a proactive step by initiating a full voluntary recall in coordination with federal authorities.
In total, 13,872 cases of the Artificial Tears Ophthalmic Solution have been recalled. These products are identified under the National Drug Code 50268-043-15 and were shipped between May 26, 2023, and April 21, 2025. Expiration dates on the affected products range from April 2025 through March 2027. Full details including specific lot numbers and expiration dates are available through AvKARE and FDA websites for anyone needing to verify whether they have an impacted product.
Consumers who have purchased or are currently using any of the recalled eye drops are being advised to stop using them immediately. To receive a refund, AvKARE has provided a process in which customers can submit a recall form. After submitting the form via fax or email, the company will respond with a return authorization form. Customers can then ship the product back and receive a full refund, including shipping costs.
Pharmaceutical recalls of this nature are not uncommon but are taken seriously due to the sensitive nature of products like eye drops, which have direct contact with mucous membranes and carry a greater risk if contaminated or compromised. This recall highlights the importance of regular oversight and strict manufacturing standards in the over-the-counter pharmaceutical industry.
Patients who experience any unusual symptoms after using the affected products, such as eye irritation, redness, or vision problems, should consult a healthcare provider promptly. While no injuries have been confirmed in connection with the recalled items, consumer safety remains a top priority. The recall also serves as a reminder for individuals to stay informed about product safety notices and to check FDA updates periodically for potential risks associated with everyday medications and treatments.
The response from AvKARE demonstrates accountability and a commitment to product safety, but it also underscores the vital role of regulatory agencies like the FDA in identifying and addressing public health concerns in a timely manner. Consumers with questions can reach out to AvKARE’s customer service team or refer to their website for more details on the return process and updated safety information.
